If trial endpoints meet expectations, FDA approval could come in coming years
Over the past decade, regulators started approving them as treatments for weight loss first as liraglutide, sold under the brand Saxenda and, more recently, in the form of semaglutide or tirzepatide, under brands like Wegovy and Zepbound
Patients in the 1 mg group reduced 8.7% of body weight, those in the 4 mg group lost 17.1%, those in the 8 mg group reached 22.8%, and those in the 12 mg group achieved 24.2% compared to 2.1% in the placebo
This copper-binding tripeptide has been known since the 1970s, and it is backed by copious research showing that it works to improve skin health and healing
Learn more about each ingredient in Lipo-C, and how injections may be a useful addition to your fat loss plan
Not without data